Other Stories

Full Video

WHO-led program plans to buy antiviral COVID-19 pills to treat 120 million patients globally Updated: 2021-10-20 15:20:02 KST

A program led by the World Health Organization plans to secure antiviral drugs, such as Merck’s experimental pill molnupiravir as part of efforts to ensure fair access to virus treatments.
Known as the Access to COVID-19 Tools Accelerator, the program aims to deliver around one billion coronavirus tests to poorer countries along with drugs to treat up to 120 million patients.
To pay for the planned purchase, the program has asked the G20 and other donors for funding of 22.8 billion U.S. dollars.
So far, donors have pledged more than 18 billion dollars to support the program.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.